ES2155825T3 - Compuestos para inmunoensayos de polarizacion de fluorescencia, e inmunoensayos que utilizan los mismos. - Google Patents

Compuestos para inmunoensayos de polarizacion de fluorescencia, e inmunoensayos que utilizan los mismos.

Info

Publication number
ES2155825T3
ES2155825T3 ES93117546T ES93117546T ES2155825T3 ES 2155825 T3 ES2155825 T3 ES 2155825T3 ES 93117546 T ES93117546 T ES 93117546T ES 93117546 T ES93117546 T ES 93117546T ES 2155825 T3 ES2155825 T3 ES 2155825T3
Authority
ES
Spain
Prior art keywords
immunoensays
compounds
fluorescence polarization
binding
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93117546T
Other languages
English (en)
Inventor
Raymond Albert Hui
Kathryn Sarah Schwenzer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2155825T3 publication Critical patent/ES2155825T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Luminescent Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

COMPUESTOS DE LA FORMULA EN DONDE F ES UN COMPUESTO FLUORESCENTE; Y ES -NH DENA DE ALKILENO RECTA O RAMIFICADA CON DE 2 A 10 ATOMOS DE CARBONO SUSTITUIDA POR AL MENOS UN GRUPO HIDROFILICO; Q ES OXIGENO O AZUFRE; Y X ES UN ANALOGO DE UN LIGANDO, SIENDO EL ANALOGO DEL LIGANDO CAPAZ DE SER RECONOCIDO POR UN ANTICUERPO ESPECIFICO AL LIGANDO CORRESPONDIENTE. ESTOS COMPUESTOS PRESENTAN UNAS PROPIEDADES MEJORADAS EN LOS INMUNOENSAYOS DE POLARIZACION POR FLUORESCENCIA YA QUE POSEEN BIEN UNA MAYOR INTENSIDAD Y/O DURAN MAS TIEMPO.
ES93117546T 1992-11-10 1993-10-29 Compuestos para inmunoensayos de polarizacion de fluorescencia, e inmunoensayos que utilizan los mismos. Expired - Lifetime ES2155825T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/974,397 US5315015A (en) 1992-11-10 1992-11-10 Compounds having improved fluorescence in fluorescence polarization immunoassays and immunoassays utilizing same

Publications (1)

Publication Number Publication Date
ES2155825T3 true ES2155825T3 (es) 2001-06-01

Family

ID=25521991

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93117546T Expired - Lifetime ES2155825T3 (es) 1992-11-10 1993-10-29 Compuestos para inmunoensayos de polarizacion de fluorescencia, e inmunoensayos que utilizan los mismos.

Country Status (6)

Country Link
US (1) US5315015A (es)
EP (1) EP0597333B1 (es)
JP (2) JP3264757B2 (es)
CA (1) CA2108919A1 (es)
DE (1) DE69329963T2 (es)
ES (1) ES2155825T3 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817766A (en) * 1995-04-05 1998-10-06 Roche Diagnostic Systems, Inc. Reagents for a cannabinoid immunoassay
AU1618697A (en) * 1996-02-06 1997-08-28 Japan Tobacco Inc. Novel compounds and pharmaceutical use thereof
US6110750A (en) * 1996-06-28 2000-08-29 Sugden; Edward A. Rapid detection method of Mycobacterium bovis by fluorescence polarization
US6071748A (en) * 1997-07-16 2000-06-06 Ljl Biosystems, Inc. Light detection device
US6097025A (en) * 1997-10-31 2000-08-01 Ljl Biosystems, Inc. Light detection device having an optical-path switching mechanism
US6469311B1 (en) 1997-07-16 2002-10-22 Molecular Devices Corporation Detection device for light transmitted from a sensed volume
US7070921B2 (en) 2000-04-28 2006-07-04 Molecular Devices Corporation Molecular modification assays
US7632651B2 (en) 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
US7745142B2 (en) 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
US6825921B1 (en) 1999-11-10 2004-11-30 Molecular Devices Corporation Multi-mode light detection system
US6992761B2 (en) * 1997-09-20 2006-01-31 Molecular Devices Corporation Broad range light detection system
US6326605B1 (en) 1998-02-20 2001-12-04 Ljl Biosystems, Inc. Broad range light detection system
US6297018B1 (en) 1998-04-17 2001-10-02 Ljl Biosystems, Inc. Methods and apparatus for detecting nucleic acid polymorphisms
US6576476B1 (en) 1998-09-02 2003-06-10 Ljl Biosystems, Inc. Chemiluminescence detection method and device
US6982431B2 (en) 1998-08-31 2006-01-03 Molecular Devices Corporation Sample analysis systems
WO2000050877A1 (en) 1999-02-23 2000-08-31 Ljl Biosystems, Inc. Frequency-domain light detection device
US6162829A (en) * 1997-10-17 2000-12-19 Atlantic Pharmaceuticals, Inc. (3R,4R)-Δ8 -tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics
AU5667599A (en) 1998-07-27 2000-02-21 Ljl Biosystems, Inc. Apparatus and methods for time-resolved spectroscopic measurements
AU5223899A (en) 1998-07-27 2000-02-21 Ljl Biosystems, Inc. Apparatus and methods for spectroscopic measurements
WO2003070697A1 (fr) * 2002-02-25 2003-08-28 Chugai Seiyaku Kabushiki Kaisha Procede de dosage de l'activite de liaison a un recepteur de la vitamine d3, utilisant la polarisation de fluorescence
US20110098309A1 (en) * 2007-07-12 2011-04-28 Acumen Pharmaceuticals, Inc. Methods of inhibiting the formation of amyloid-beta diffusable ligands using acylhydrazide compounds
US9006283B2 (en) * 2007-07-12 2015-04-14 Acumen Pharmaceuticals, Inc. Methods of modifying amyloid β oligomers using non-peptidic compounds
US8962677B2 (en) * 2007-07-12 2015-02-24 Acumen Pharmaceuticals, Inc. Methods of restoring cognitive ability using non-peptidic compounds
WO2009079566A2 (en) 2007-12-18 2009-06-25 Acumen Pharmaceuticals, Inc. Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production
WO2011140333A1 (en) 2010-05-07 2011-11-10 The Board Of Trustees Of The Leland Stanford Junior University Identification of stabilizers of multimeric proteins
US20160045609A1 (en) 2014-08-14 2016-02-18 Mamoun M. Alhamadsheh Conjugation of pharmaceutically active agents with transthyretin ligands through adjustable linkers to increase serum half-life
CN116730920A (zh) 2017-02-17 2023-09-12 文涵治疗有限公司 Ag-10的制备方法、其中间体及其盐
MA52137A (fr) 2018-03-23 2021-01-27 Eidos Therapeutics Inc Méthodes de traitement de l'amylose ttr à l'aide d'ag10
AU2019321583C1 (en) 2018-08-17 2025-11-27 Eidos Therapeutics, Inc. Formulations of AG10

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255329A (en) * 1973-10-02 1981-03-10 Syva Company Double receptor fluorescent immunoassay
NZ199629A (en) * 1981-02-17 1984-11-09 Abbott Lab Fluorescent polarisation immunoassay and certain substituted carboxy fluoresceins
US4668640A (en) * 1981-12-11 1987-05-26 Abbott Laboratories Fluorescence polarization immunoassay utilizing substituted carboxyfluoresceins
US4476229A (en) * 1982-11-08 1984-10-09 Abbott Laboratories Substituted carboxyfluoresceins
US4476228A (en) * 1982-11-08 1984-10-09 Abbott Laboratories Determination of unsaturated thyroxine binding protein sites using fluorescence polarization techniques
US4833073A (en) * 1987-01-27 1989-05-23 Hoffmann-La Roche Inc. Immunoassay for tetrahydrocannabinol metabolites

Also Published As

Publication number Publication date
EP0597333B1 (en) 2001-02-28
JPH06211867A (ja) 1994-08-02
JP3264757B2 (ja) 2002-03-11
DE69329963D1 (de) 2001-04-05
JP2002022741A (ja) 2002-01-23
DE69329963T2 (de) 2001-09-13
EP0597333A3 (en) 1995-05-10
CA2108919A1 (en) 1994-05-11
US5315015A (en) 1994-05-24
EP0597333A2 (en) 1994-05-18

Similar Documents

Publication Publication Date Title
KR880010183A (ko) 폴리에스테르 섬유재료 염색물의 광화학적 안정성을 향상시키는 방법
ES2121030T3 (es) Arilacetamidas.
PT80683A (de) Verfahren zur herstellung von neue n-(2-nitrophenyl)-2-amino-pyrimidin-derivate
ATE40122T1 (de) N-(2-nitrophenyl)-2-aminopyrimidin-derivate, deren herstellung und verwendung.
DE69435118D1 (de) Gereinigte Zusammensetzungen von Newcastle-Krankheitvirus
ES2196305T3 (es) Composiciones que contienen moleculas inmunogenas y factor de estimulacion de colonias de granulocitos magrofagos como adyuvante.
PT99436A (pt) Processo para a preparacao de derivados de amino-sulfonil-carbamatos e de com- posicoes farmaceuticas que os contem
ES2082434T3 (es) Compuestos de tetrametilpiperidina para su utilizacion como estabilizantes para materiales organicos.
MX168036B (es) Agente presulfurador para la preparacion de catalizadores de hidrotratamiento
DK0559898T3 (da) Anilidderivater
ES2086326T3 (es) Metodo para intensificar la quimiluminiscencia.
PT90938A (pt) Processo para a preparacao de novas sulfonamidas e de composicoes farmaceuticas que as contem
ATE2017T1 (de) Mischungen von optischen aufhellern und deren verwendung.
MX9304399A (es) Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados.
ES2099013B1 (es) Nuevos compuestos de polimetilpiperidina con grupos de silano y su uso como estabilizantes para materiales organicos.
ES2038092T1 (es) Un compuesto de dioxetano.
ES2088633T3 (es) Estabilizantes polisiloxanicos que contienen grupos fenol y grupos oxamidicos estericamente impedidos.
DE3875346D1 (de) Zusammensetzungen, die mit 1-oxo- oder thiokohlenwassserstoff substituierte azacycloalkane enthalten.
MX9301079A (es) Metodos de acabado de fibra.
ATE6375T1 (de) Mischungen von optischen aufhellern und deren verwendung.
ATE76405T1 (de) 2-trifluormethyl-benzimidazole.
DE59408281D1 (de) Neue cyclische Depsipeptide mit 18 Ringatomen und ihre Verwendung zur Bekämpfung von Endoparasiten
ES8502147A1 (es) Procedimiento para la produccion de compuestos poliazoicos
BR8804930A (pt) Processo para obtencao de derivados de o-(o-etil-s-alquilfosforil)-o-(carbamoil)-pirocatecol e respectiva composicao pesticida
ES2074689T3 (es) Neopentil sulfatos con perfluoroalquil terminal conteniendo un heteroatomo y sus sales.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 597333

Country of ref document: ES